Page 1705 - Clinical Small Animal Internal Medicine
P. 1705

Index  1643

                 see also individual agents/diseases  wash‐out  24                   mammary cancer  1322, 1322,
  VetBooks.ir  viremia  878–880                  water deprivation test (WDT)        mast cell tumors  1361
               viral papillomas  1261
                                                 water balance see sodium and water
                                                                                      1324, 1324
                                                     homeostasis
               virtual endoscopy  500, 500
               virulent babesiosis  108              67–68                           melanoma  1352, 1352
                                                                                     oral tumors  1254
               visceral hemangiosarcoma  1340, 1344  weight change/management      World Small Animal Veterinary
               visceral myopathy  570              cardiovascular disease             Association (WSAVA)
               viscoelastic coagulation testing      120–121                         canine inflammatory liver
                   315, 316–317, 317               diabetes mellitus  94              disease  695
               vision  736–738                     osteoarthritis  1532–1533         chronic enteropathies  635
               vitamin D deficiency  1524–1527   Westermark sign  316, 316           endoscopy  508
               vitamin D‐dependent rickets type I/  western immunoblotting  910      feline inflammatory liver
                   II  1527                      West Nile virus (WNV)  899–900       disease  687
               vitamin K1 antagonists  438–439     diagnosis  900                    hepatobiliary disease  659, 667
               vitamin K agonists  322             epidemiology  899                 kennels and multicat
               vitamin supplementation  693,       etiology/pathophysiology  899      environments  1064
                   702, 1487                       prognosis  900                  wounds and wound management
               vocalization  893                   public health implications  900   bandaging  1032
               Vogt–Koyanagi–Harada‐like           signalment  899                   critical care setting  352
                   syndrome  1430–1431             treatment  900                    exploration and initial
               voiding urohydropropulsion        wheals  1384, 1407                   debridement  1031
                   (VUH)  1144–1145, 1146        wheezes  125                        lavage  1032
               volvulus/torsion  496–497, 504, 505  WHO see World Health Organization  nocosomial and multidrug‐resistant
                 see also gastric dilation‐volvulus  wild mammals                     infections  1058
               vomiting                            leptospirosis  945–946            surgical and traumatic wound
                 acute kidney injury  1097–1098    rabies  891–895                    infections  1029–1032, 1030–1031
                 acute poisoning  441–442          yersiniosis  951–952              surgical, traumatic, and bite wound
                 chronic kidney disease  1167–1168  wipes  1398, 1469                 infections  1032
                 endocrine manifestations of cancer     withdrawal‐flexor reflex  734–735  trauma and burns  450, 455
                   1215–1216                     WM see Waldenström                  venomous snake bites  462, 463
                 feline inflammatory liver disease     macroglobulinemia             wound closure  1032
                   688, 693                      WNV see West Nile virus             wound preparation  1031
                 feline parvovirus  870          Wolbachia pipientis                 see also bite wounds
                 gallbladder and extrahepatic biliary   infection  917–918         WSAVA see World Small Animal
                   ducts  723                      diagnosis  918                     Veterinary Association
                 metabolic diseases  679–680       epidemiology  918
                 motility disorders  565–567,      etiology/pathophysiology  917   x
                   570–572, 580                    history and clinical signs  918  xanthine urolithiasis  1128–1129, 1128
               von Willebrand factor (vWF)  460    prognosis  918                  xanthomas  1483
               VPC see ventricular premature       public health implications  918  xenogeneic DNA vaccination
                   depolarizations/contractions    signalment  918                    1349–1350, 1350
               V–Q see ventilation–perfusion       treatment  918                  xylitol toxicity  109–110
               VRA see vascular ring anomalies   Wolff–Parkinson–White
               VRE see vancomycin‐resistant          syndrome  414                 y
                   enterococci                   Wood’s lamp examination           yersiniosis  951–954
               VSD see ventricular septal defect     439–440, 987                    diagnosis  953
               VT see ventricular tachycardia    World Health Organization (WHO)     epidemiology  952
               VUH see voiding urohydropropulsion  approach to the cancer            etiology/pathophysiology  951
               vWF see von Willebrand factor         patient  1200                   history and clinical signs  952–953
                                                   hemangiosarcoma  1341–1342,       prevention  953–954
               w                                     1342                            prognosis  953
               Walchia americana  1459–1460        kennels and multicat              public health implications  954
               Waldenström macroglobulinemia         environments  1064              signalment  952
                   (WM)  1241–1246                 lymphomas  1231–1232, 1232        treatment  953
   1700   1701   1702   1703   1704   1705   1706